Glaukos Corporation
GKOS
$83.86
$2.072.53%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/8/2025
-
Simply Wall St
11/6/2025
-
Simply Wall St
11/6/2025
-
Fool.com Headlines
11/3/2025
-
Insider Monkey
11/3/2025
-
GuruFocus
11/3/2025
-
Business Wire
11/3/2025
-
MarketBeat
11/3/2025
-
MarketBeat
11/3/2025
-
Simply Wall St
11/1/2025
-
MarketBeat
11/1/2025
-
Simply Wall St
11/1/2025
-
MarketBeat
10/31/2025
-
MarketBeat
10/31/2025
-
MarketBeat
10/31/2025
-
MarketBeat
10/31/2025
-
Insider Monkey
10/31/2025
-
Tickeron - Stocks
10/31/2025
-
Tickeron - Stocks
10/31/2025
-
TipRanks Financial Blog
10/31/2025
-
Simply Wall St
10/31/2025
-
MarketBeat
10/30/2025
-
Fool.com Headlines
10/30/2025
-
Nasdaq News: Markets
10/30/2025
-
GuruFocus
10/30/2025
-
Fool.com Headlines
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, October 31, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
949 367 9600
Address
One Glaukos Way
Aliso Viejo, CA 92656
Aliso Viejo, CA 92656
Country
Year Founded
Business Description
Sector
Industry
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States...
more